Cardiopulmonary bypass using argatroban as an anticoagulant for a 6.0-kg pediatric patient

Journal of Extra-Corporeal Technology

Volumn 37, Issue 3, 2005, Pages 303-305

  Mejak, Brian ^a   Giacomuzzi, Carmen ^a   Shen, Irving ^a   Boshkov, Lynn ^a   Ungerleider, Ross ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Anticoagulants; Argatroban; Cardiopulmonary bypass; Pediatric; Thrombosis

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBIN III; ARGATROBAN; FIBRINOLYTIC AGENT; HEPARIN;

ANTICOAGULATION; AORTA ARCH INTERRUPTION; ARTICLE; BLALOCK TAUSSIG ANASTOMOSIS; BLOOD CLOTTING TIME; BODY WEIGHT; BRADYCARDIA; CARDIOPULMONARY BYPASS; CASE REPORT; DISEASE SEVERITY; EXTRACORPOREAL OXYGENATION; FEMALE; GREAT VESSELS TRANSPOSITION; HEART RIGHT VENTRICLE DOUBLE OUTLET; HEART VENTRICLE SEPTUM DEFECT; HUMAN; HYPOXIA; INFANT; OPERATING ROOM; PEDIATRIC SURGERY; POSTOPERATIVE THROMBOSIS; PULMONARY ARTERY; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

EID: 31544441948     PISSN: 00221058     EISSN: 29698960     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Alsoufi B, Boshkov LK, Kirby A, et al. Heparin-induced thrombocytopenia (HIT) in pediatric cardiac surgery: an emerging cause of morbidity and mortality. Semin Thorac Cardiovasc Surg Pediatr Card Surg Ann. 2004;7:155-71.
2. Edwards J, Hamby J, Worrall N. Successful use of argatroban as a heparin substitute during cardiopulmonary bypass: Heparin-induced thrombocytopenia in a high-risk cardiac surgical patient. Ann Thorac Surg. 2003;75:1622-4.
3. Gasparovic H, Nathan N, Fitzgerald D, Aranki S. Severe argatroban-induced coagulopathy in a patient with a history of heparin-induced thrombocytopenia. Ann Thorac Surg. 2004;78:89-91.
4. Mejak B, Giacomuzzi C, Heller E, et al. Argatroban usage for anti-coagulation for ECMO on a post-cardiac patient with heparin-induced thrombocytopenia. J. Extra Corpor Technol. 2004;36:178-81.
5. Johnston N, Wait M, Huber L. Argatroban in adult extracorporeal membrane oxygenation. J Extra Corpor Technol. 2002;34:281-4.
6. Tanaka K, Szlam F, Katori N, Sato N, Vega J, Levy J. The effects of argatroban on thrombin generation and hemostatic activation in vitro. Anesth Analg. 2004;99:1283-9.
7. Young G, Yonekawa K, Nakagawa P, Nugent D. Argatroban as an alternative to heparin in extracorporeal membrane oxygenation circuits. Perfusion. 2004;19:283-8.
8. Kawada T, Kitagawa H, Hoson M, Okada Y, Shiomura J. Clinical application of argatroban as an alternative anticoagulant for extracorporeal circulation. Blood Stasis Thromb. 2000;14:445-57.